OSCR

Thalamic homeostatic transcriptomic signatures are altered in a mouse model of cholestatic liver injury and are mitigated by systemic TNF neutralization.

Overview

Authors: Wagdi Almishri1, Jeff F. Dunn2, Mark G. Swain3
  1. Department of Medicine, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary,Calgary, AB Canada
  2. Hotchkiss Brain Institute, Department of Radiology, Experimental Imaging Centre, Cumming School of Medicine, University of Calgary,Calgary, AB Canada
  3. Calgary Liver Unit, Department of Medicine, Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary,Calgary, AB Canada
Institutions: University of Calgary (Canada)
Journal: Molecular brain, volume 19, issue 1, article 28
Dates: received 23 September 2025; accepted 6 April 2026; published online 18 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1186/s13041-026-01302-5 · PMID 41998777 · PMCID PMC13097699 · OpenAlex W7154693268
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: genetics / omics (modality), mouse (organism), cellular / molecular (subfield)
Keywords: Fatigue, Brain, Liver-brain axis, Sickness‑behavior, Immune-mediated liver diseases, Cholestasis
MeSH: Antibodies, Neutralizing*, Cholestasis*, Gene Expression Profiling*, Homeostasis*, Liver*, Thalamus*, Transcriptome*, Tumor Necrosis Factor-alpha*, Animals, Cell Proliferation, Disease Models, Animal, Male, Mice, Inbred C57BL (* major topic)
Topic: Liver Diseases and Immunity (Hepatology, Medicine), according to OpenAlex
Funding: This work was supported by the Cal Wenzel Family Foundation Chair in Hepatology (held by MGS)
Citations: not cited yet (Europe PMC); 61 references in the paper

Abstract

Cholestatic liver diseases (CLD), including PBC and PSC, are frequently associated with debilitating sickness‑behavior symptoms such as fatigue, cognitive impairment, and anxiety/depression, which have poorly defined etiology and limited treatment options, substantially reducing quality of life. Across immune‑mediated diseases, thalamic changes have been well documented and found to correlate with a number of theses symptoms. Changes in thalamic structure and neural connectivity have been previously identified in PBC patients by us and other groups. These changes include findings indicating reduced tissue neuronal density and myelination, decreased thalamic size, and changes in functional neural connectivity between the thalamus and basal ganglia and cortical behavior-regulating areas that correlated with symptom severity. These observations implicate altered thalamic structure and function in the genesis of CLD-related sickness‑behavior symptoms. Therefore, we used a well characterized mouse model of CLD due to bile duct ligation (BDL) to mechanistically examine how CLD impacts thalamic structure and function. BDL mice showed reduced thalamic volume compared to sham-ligated controls, as determined by MRI, and an altered thalamic RNA–seq transcriptomic signature with predicted molecular activity consistent with inhibition of cellular growth, proliferation, neurite formation, neural function, and myelination, as well as enhanced apoptosis. Additionally, BDL was associated with changes in gene expression for key thalamic nervous system signaling pathways that regulate neurotransmission and behavior. We have previously demonstrated that systemic TNF is a key regulator of liver-to-brain communication and the development of adverse behavioral symptoms in BDL mice. Therefore, we administered anti-TNF antibody to neutralize systemic TNF in BDL mice and determined the impact on thalamic transcriptomic changes. TNF neutralization attenuated BDL-associated thalamic transcriptomic changes and enhanced gene expression in pathways regulating neurotransmission, cell proliferation, and those associated with neuron survival, although myelination pathways remained unaltered. We show that reduced thalamic volume in BDL mice is associated with transcriptomic alterations suggesting inhibition of structural machinery and dysfunction of neural signaling; findings that are significantly attenuated after systemic TNF neutralization. Our findings suggest that TNF inhibition may represent a potential novel approach to attenuate thalamic changes in CLD.

Supplementary Information: The online version contains supplementary material available at 10.1186/s13041-026-01302-5.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

Data supporting the results reported in this manuscript are available upon request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 3 authors, 6 keywords, 13 MeSH terms, 1 funder, 61 references.

Cite

This paper

Almishri, W., Dunn, J. F., & Swain, M. G. (2026). Thalamic homeostatic transcriptomic signatures are altered in a mouse model of cholestatic liver injury and are mitigated by systemic TNF neutralization. Molecular brain, 19(1), 28. https://doi.org/10.1186/s13041-026-01302-5

BibTeX

@article{almishri2026thalamic,
author = {Almishri, Wagdi and Dunn, Jeff F. and Swain, Mark G.},
title = {{Thalamic homeostatic transcriptomic signatures are altered in a mouse model of cholestatic liver injury and are mitigated by systemic TNF neutralization}},
journal = {Molecular brain},
year = {2026},
month = apr,
volume = {19},
number = {1},
pages = {28},
publisher = {BMC},
issn = {1756-6606},
doi = {10.1186/s13041-026-01302-5},
url = {https://doi.org/10.1186/s13041-026-01302-5},
pmid = {41998777},
pmcid = {PMC13097699}
}

RIS

TY - JOUR
AU - Almishri, Wagdi
AU - Dunn, Jeff F.
AU - Swain, Mark G.
TI - Thalamic homeostatic transcriptomic signatures are altered in a mouse model of cholestatic liver injury and are mitigated by systemic TNF neutralization
T2 - Molecular brain
J2 - Mol Brain
PY - 2026
DA - 2026/04/18
VL - 19
IS - 1
SP - 28
SN - 1756-6606
PB - BMC
DO - 10.1186/s13041-026-01302-5
UR - https://doi.org/10.1186/s13041-026-01302-5
LA - en
ER -

CSL-JSON

{
"id": "10.1186/s13041-026-01302-5",
"type": "article-journal",
"title": "Thalamic homeostatic transcriptomic signatures are altered in a mouse model of cholestatic liver injury and are mitigated by systemic TNF neutralization",
"container-title": "Molecular brain",
"author": [
{
"family": "Almishri",
"given": "Wagdi"
},
{
"family": "Dunn",
"given": "Jeff F."
},
{
"family": "Swain",
"given": "Mark G."
}
],
"container-title-short": "Mol Brain",
"volume": "19",
"issue": "1",
"page": "28",
"DOI": "10.1186/s13041-026-01302-5",
"PMID": "41998777",
"PMCID": "PMC13097699",
"ISSN": "1756-6606",
"publisher": "BMC",
"URL": "https://doi.org/10.1186/s13041-026-01302-5",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
18
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1002/mco2.70931 [code]
Unveiling Functional Architecture of Human Thalamus: AStereoelectroencephalography Study.
Journal: MedComm
In common: 4 references
[2] doi:10.1126/sciadv.aef5358 [code]
Thalamic modulation of cortical linearity across arousal states.
Journal: Science advances
In common: 3 references
[3] doi:10.1038/s41467-026-71923-w [code]
Integrating optogenetic fMRI and spatial transcriptomics to reveal circuit-specific gene signatures in fronto- and hippo-thalamic networks.
Journal: Nature communications
In common: genetics / omics, mouse, 2 references
[4] doi:10.1093/braincomms/fcag134 [code]
Neurophysiological, imaging and neurobiological markers of central fatigue in multiple sclerosis.
Journal: Brain communications
In common: 2 references
[5] doi:10.1038/s41467-026-75661-x [code]
A neural signature of sleep deprivation in the human brain.
Journal: Nature communications
In common: 2 references
[6] doi:10.7554/elife.110294 [code]
Arousal modulates functional connectivity through structured and hemispherically asymmetric community architecture during wakefulness.
Journal: eLife
In common: 2 references
[7] doi:10.1038/s41467-026-71481-1 [code]
Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration.
Journal: Nature communications
In common: 2 references
[8] doi:10.1002/glia.70142
The Ubiquitin Ligase Zinc Finger SWIM Domain-Containing Protein 8 Regulates Oligodendrocyte Development Through the Argonaute2/MicroRNA-7 Axis.
Journal: Glia
In common: mouse, cellular / molecular, 1 reference
[9] doi:10.1128/jvi.02063-25
HIV transgenic mouse monocytes display increased <i>in vivo</i> migration across the blood-brain barrier associated with increased expression of genes associated with mononuclear leukocyte movement.
Journal: Journal of virology
In common: mouse, cellular / molecular, 1 reference
[10] doi:10.1016/j.isci.2026.117412 [code]
Transcriptomic landscape of microglia in mouse models of social dysfunction and oxytocin-mediated recovery.
Journal: iScience
In common: genetics / omics, mouse, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.